Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

@article{Bruijn2016IntroductionAU,
  title={Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future},
  author={Winnie de Bruijn and C. Ib{\'a}{\~n}ez and P. Frisk and Hanne Bak Pedersen and A. Alkan and Patricia Vella Bonanno and L. S. Brki{\vc}i{\'c} and A. Bucsics and G. Dedet and J. Eriksen and J. Fadare and Jurij F{\"u}rst and G. Gallego and I. God{\'o}i and A. G. Guerra J{\'u}nior and Hakkı G{\"u}rs{\"o}z and S. Jan and J. Jones and R. Joppi and S. Kerman and O. Laius and Newman Madzikwa and Einar Magn{\'u}sson and M. Maticic and Vanda Markovi{\'c}-Pekovi{\'c} and A. Massele and O. Ogunleye and A. O'Leary and Jutta Piessnegger and C. Sermet and S. Simoens and C. Tiroyakgosi and I. Truter and Magnus Thyberg and K. Tomekova and M. Władysiuk and Sotiris Vandoros and E. H. Vural and C. Zara and B. Godman},
  journal={Frontiers in Pharmacology},
  year={2016},
  volume={7}
}
Background: Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a diagnosed prevalence of 2.0%. Fortunately, it is now curable in most patients. Sales of medicines to treat HCV infection grew 2.7% per year between 2004 and 2011, enhanced by the launch of the protease inhibitors (PIs) boceprevir (BCV) and telaprevir (TVR) in addition to ribavirin and pegylated interferon (pegIFN). Costs will continue to rise with new treatments including sofosbuvir, which now… Expand
27 Citations
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program
  • 6
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
  • 52
  • PDF
Economically Efficient Hepatitis C Virus Treatment Prioritization Improves Health Outcomes
  • 5
...
1
2
3
...

References

SHOWING 1-10 OF 136 REFERENCES
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
  • 174
  • PDF
Predicted effects of treatment for HCV infection vary among European countries.
  • 119
  • PDF
New expensive treatments for hepatitis C infection.
  • 89
  • Highly Influential
A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients
  • 23
  • Highly Influential
Treatment of hepatitis C: a systematic review.
  • 378
  • Highly Influential
  • PDF
...
1
2
3
4
5
...